Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis

Since novel treatments to target eosinophilic inflammation in Type 2 asthma are emerging, we aimed to evaluate and meta-analyze the efficacy of monoclonal antibodies to reduce exacerbation rate. PubMed and Web of Science were searched for phase II and phase III randomized clinical trials with monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Edris, Ahmed, De Feyter, Silke, Maes, Tania, Joos, Guy, Lahousse, Lies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688359/
https://www.ncbi.nlm.nih.gov/pubmed/31395084
http://dx.doi.org/10.1186/s12931-019-1138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688359/
https://www.ncbi.nlm.nih.gov/pubmed/31395084
http://dx.doi.org/10.1186/s12931-019-1138-3

Ejemplares similares